Thiopurine therapy enhances immune checkpoint inhibitor efficacy in low-mutational burden melanoma: A promising anticancer approach
Proc Natl Acad Sci U S A. 2025 Mar 4;122(9):e2423246122. doi: 10.1073/pnas.2423246122. Epub 2025 Feb 24. ABSTRACT A key limitation of immune checkpoint inhibitors (ICI) …